Jones Financial Companies
CRBP icon

Jones Financial Companies’s Corbus Pharmaceuticals CRBP Stock Holding History

Jones Financial Companies’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$621 Hold
71
– – ﹤0.01% 4716
2026
Q1 		$618 Sell
71
-150
-68% -$1.26K ﹤0.01% 4457
2025
Q4 		$1.8K Hold
221
– – ﹤0.01% 3849
2025
Q3 		$2.68K Buy
221
+8
+4% +$76 ﹤0.01% 3592
2025
Q2 		$1.58K Buy
213
+150
+238% +$1.09K ﹤0.01% 3541
2025
Q1 		$348 Sell
63
-34
-35% -$300 ﹤0.01% 3553
2024
Q4 		$1.15K Buy
97
+86
+782% +$1.44K ﹤0.01% 3110
2024
Q3 		$230 Buy
+11
New +$563 ﹤0.01% 2935

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Jones Financial Companies's CRBP Position: Q2 2026 in Review

Jones Financial Companies held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 71 shares worth $621. The position accounts for ﹤0.01% of the portfolio, ranked #4716.

Jones Financial Companies first reported a position in CRBP in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.68K in Q3 2025. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Jones Financial Companies held 71 shares of Corbus Pharmaceuticals worth $621 as of Q2 2026.
  • Jones Financial Companies left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4716 holding.
  • Jones Financial Companies first reported a position in Corbus Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Corbus Pharmaceuticals position peaked at $2.68K in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.